Explore detailed IPO reviews, sector analysis and educational guides to help you invest with more confidence.
Check the latest upcoming IPOs in India, including SRIT India, Shah Investor's Home, Vishal Nirmiti, Nityas Gems and 16 SME IPOs. Get price bands, issue sizes, dates and GMP updates.
Kwick Forensic Solutions IPO is witnessing exceptionally strong investor demand ahead of its August 31 closing. The ₹50.77 crore BSE SME IPO is priced at ₹85–₹90 per share, with a lot size of 1,600 shares. The latest available subscription data shows the issue subscribed 19.29x, led by retail investors at 36.23x and NIIs at 9.05x. GMP has climbed to around ₹70, indicating an unofficial premium of nearly 78% over the upper price band. The company provides forensic science, fingerprint, cyber/digital forensics and law-enforcement solutions across India.
Three IPOs are opening and eight companies are set to list in the first week of September 2026. Check the latest IPO GMP, subscription and listing updates.
September 2026 could be a major month for Indian IPOs. Check the NSE IPO, Deepa Jewellers, Rays of Belief, Purple Style Labs and latest GMP trends.
Check the latest IPO GMP, subscription trends and upcoming IPOs as August 2026 ends. Track Hy-Tech Engineers, Symbiotec Pharmalab, Skyways Air and more.
Lumino Industries IPO opened for subscription on August 27, 2026, with strong grey-market interest. The ₹700 crore mainboard IPO is priced at ₹78–₹82 per share and includes a ₹500 crore fresh issue plus ₹200 crore OFS. The power cable and EPC company reported FY2026 revenue of ₹2,041.07 crore and PAT of ₹160 crore, while its order book stood at ₹3,149.8 crore. With GMP indicating around 61% potential listing gains, investors are watching opening-day demand, debt reduction and future power-infrastructure growth.
Kwick Forensic Solutions IPO opened on August 27, 2026, with a strong grey-market buzz. The ₹50.77 crore BSE SME issue is priced at ₹85–₹90 per share and includes a ₹41.05 crore fresh issue plus ₹9.72 crore OFS. The forensic technology company reported FY2026 revenue of ₹105.80 crore and PAT of ₹13.51 crore. Around ₹31.42 crore of IPO proceeds will fund working-capital requirements. With GMP indicating about 71% premium before bidding began, investors are watching subscription demand, government-sector opportunities and the sustainability of the company's rapid recent growth.
Sumax Engineering IPO gained strong momentum on August 27, 2026, with overall subscription reaching about 8.91 times in the latest available update. Retail demand led the issue at 17.15x, while NII subscription stood at 5.13x. The ₹53.40 crore NSE SME IPO is priced at ₹95–₹101 and closes on August 28. FY2026 revenue stood at ₹148.34 crore with PAT of ₹12.76 crore. Fresh proceeds will primarily support two proposed manufacturing facilities and working-capital requirements.
Hy-Tech Engineers IPO entered its final day on August 27, 2026, with exceptional investor demand. The ₹135.73 crore mainboard IPO, priced at ₹50–₹53 per share, was subscribed over 50 times in the latest update. Grey market sentiment has strengthened significantly, with GMP indicating an estimated 83% premium over the issue price. The engineering company plans to use IPO proceeds for working capital, capital expenditure and general corporate purposes. Investors are now focused on final subscription figures, allotment and the September listing.
Symbiotec Pharmalab IPO entered its final bidding day on August 27, 2026, with strong investor participation. The ₹1,757 crore mainboard IPO, priced at ₹938–₹988 per share, was subscribed around 5.63 times as of 10:03 AM, led by NII and retail investors. The latest reported GMP stands near ₹285, indicating an estimated 29% premium over the upper issue price. The pharmaceutical and biotechnology company reported FY2026 revenue of ₹869.15 crore and PAT of ₹109.90 crore. With only ₹150 crore of the IPO coming through fresh shares and ₹1,607 crore through OFS, investors will be watching final subscription, institutional demand, debt reduction and post-listing growth.
Are you interested in getting our mobile app?
